Kensey Nash Corporation is the recipient of the 2005 Excellence in Technology of the Year Award in cardiac embolic protection systems from Frost & Sullivan. The award was given to Kensey Nash to recognize the company’s design and development of the triActiv® System, a new protection device that prevents debris from embolization during stenting procedures.
During many coronary bypass procedures, the saphenous vein is removed from the patient’s leg(s) and is used as a replacement for diseased or occluded native coronary arteries. Unfortunately, approximately half of these saphenous vein grafts (SVGs) become diseased or occluded within ten years of surgery.
The management of patients with diseased SVGs has long posed a challenge to cardiologists…
The TriActiv® Balloon Protected Flush Extraction System is designed to provide complete distal protection during intervention of diseased SVGs using three tools in one procedure: a protection balloon isolates the vessel and prevents distal embolization of debris; a 3 French catheter flushes any debris generated during PTCA or stenting; and a peristaltic pump extraction system provides constant uniform flushing and aspiration of debris into the guide catheter for collection and analysis. The TriActiv® System is designed to minimize acute procedural complications such as Q-wave and non Q-wave myocardial infarctions following coronary vein graft interventions.